Mckesson paid its one named executive on file $5.2M in FY2025 (Mar).
PayNo stock prices for these years
Pay of each named executive
Brian S. TylerChief Executive Officer
| FY2023 (Mar) | ||||||
| FY2022 (Mar) | ||||||
| FY2021 (Mar) | ||||||
| FY2020 (Mar) | ||||||
| FY2019 (Mar) |
5 years
Britt J. VitaloneExecutive Vice President and Chief Financial Officer
| FY2023 (Mar) | ||||||
| FY2022 (Mar) | ||||||
| FY2021 (Mar) | ||||||
| FY2020 (Mar) | ||||||
| FY2019 (Mar) | ||||||
| FY2018 (Mar) |
6 years
Michele LauExecutive Vice President and Chief Legal Officer
| FY2025 (Mar) | ||||||
| FY2024 (Mar) |
2 years
LeAnn B. SmithExecutive Vice President and Chief Human Resource Officer
| FY2023 (Mar) |
1 year
Thomas L. RodgersExecutive Vice President and Chief Strategy and Business Development Officer
| FY2023 (Mar) | ||||||
| FY2022 (Mar) |
2 years
CEO pay against the pay peers
In FY2024 (Mar), the median CEO pay of the 8 peers with pay on file was $18.1M. The CEO of Mckesson was paid $19.0M, 5% above the median.
- 1Cardinal Health
- 2Pfizer
- 3Johnson & Johnson
- 4MckessonThis company
- 5Cencora
- 6CVS HEALTH
- 7Kroger
- 8Viatris
- 9Henry Schein
- 10Owens & MinorNot disclosed
- 11Rite AidNot disclosed
- 12SanofiNot disclosed
- 13Teva PharmaceuticalNot disclosed
- 14Walgreens Boots AllianceNot disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.